A longitudinal study using data from the Alzheimer’s Disease Neuroimaging Initiative found that omega-3 fatty acid supplementation was associated with accelerated cognitive decline in older adults, challenging the common belief that omega-3 universally protects brain health. Participants taking omega-3 supplements showed faster worsening in MMSE, ADAS-Cog13, and CDR-SB scores over time. Interestingly, the association was not explained by classical Alzheimer’s disease pathologies such as amyloid-β accumulation, tau deposition, or gray matter atrophy. Instead, reduced cerebral glucose metabolism on FDG-PET scans—reflecting impaired synaptic and neuronal function in AD-vulnerable brain regions—partially mediated the relationship, accounting for 19% to 41% of the observed cognitive decline. These findings suggest that omega-3 supplementation may adversely affect cerebral synaptic function in some older adults and highlight the need for a more cautious reassessment of its widespread use for cognitive protection. Source: https://www.sciencedirect.com/
In a US longitudinal multi-omic study of 1,154 hospitalized patients with COVID-19 from the IMPACC…
The secondary analysis of a randomized clinical trial found that a low-fat vegan diet reduced…
Maintaining optimal vascular health in midlife was associated with up to 12.6 additional years of…
Restricting sugar intake during the first 1,000 days from conception was associated with a lower…
Incidental coronary artery calcium (CAC) identified on routine nongated chest CT scans predicts future coronary…
The burden of modifiable cardiovascular risk factors—not just the total number of risk factors—is strongly…
This website uses cookies.